CENPF and breast cancer: Overexpression of CENPF may correlate with poor prognosis in breast cancer [38], CENPF may be a new prognostic biomarker in nonmuscle invasive bladder cancer [39], and the HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis [40].